Du et al.439 reported that in NSCLC, the transcriptional co-activator MRTF-A (myocardin-related transcription factor-A), interacts with NF-κB/p65 rather than its common binding partner SRF (serum response factor). The gene discussed is MRTFA; the disease is non-small cell lung carcinoma.